Description of Pinealon
Pinealon is a synthetic tripeptide, likely developed within the framework of geroprotective substance research in Russia, aimed at identifying compounds that slow the aging process and may influence cognitive functions. The peptide has demonstrated significant promise in the field of neuroprotection research, particularly regarding its observed ability to safeguard cells from damage induced by aging or oxidative stress.
One of the primary effects of Pinealon observed in research is its ability to influence the function of the pineal gland, which regulates circadian rhythms and biological processes within the body. Due to this, Pinealon may be of research interest in the context of sleep quality, regulation of bodily rhythms, and regeneration during sleep. Research has shown that Pinealon may have anti-aging potential, particularly within the central nervous system, where it may influence cognitive functions such as memory and learning.
Overview of Published Research
1. Pinealon and DNA
Pinealon does not, unlike most peptides, interact with cell surface or cytoplasmic receptors, raising questions about its mechanism of action. It was previously hypothesized that its small size allows it to pass through lipid bilayers, such as cellular and nuclear membranes, and potentially interact directly with DNA. Research on cell cultures, specifically HeLa cells, has confirmed that Pinealon can penetrate not only the cytoplasm but also the nucleus, where it affects genetic information. This discovery explains how Pinealon can function as a gene expression regulator, offering new insight into its wide range of effects, which are not the result of interaction with traditional receptors.
In experiments where peptides were labeled with fluorescein, significant fluorescence was observed in both the cytoplasm and nucleus of cells, suggesting that these short biologically active peptides can penetrate the cytoplasm and nucleus, interacting with various components, including DNA and RNA. Analysis of these interactions revealed that peptides like Pinealon can specifically bind to nucleotide sequences, including those with a cytosine methylation state. This mechanism may epigenetically regulate gene activity, highlighting the significant role of Pinealon in regulating gene expression and genetic functions critical for cell development and evolution.
[1]
2. Pinealon and its Effect on Aging
Pinealon demonstrates notable anti-aging effects in research, particularly in the central nervous system, as confirmed by studies indicating that this peptide may influence biological aging markers. Studies from Russia suggest that Pinealon, along with a similar peptide, Vesugen, exhibits anabolic effects in the brain and may influence cognitive functions, with observed changes in biological aging markers. Additionally, Pinealon also has effects on muscle cells, where it influences the expression of irisin, a hormone that has been studied in the context of muscle protection during physical activity, fat metabolism, and telomere length, further contributing to research into aging and oxidative stress.
Research has also shown that plasma levels of irisin are directly associated with telomere length, suggesting that Pinealon may play a key role in the epigenetic regulation of aging. Interestingly, irisin is active not only in muscle cells but also in other tissues, which may explain the widespread observed effects of Pinealon throughout the body, including the brain. Thus, this peptide offers potential for research into overall cellular condition, cell lifespan, and metabolic processes, showing promise in investigating energy balance and bodily function during the aging process.
[2] - [4]
3. Pinealon and Neurons
Research on rats has shown that administering Pinealon to pregnant female rats with a methionine-enriched diet was associated with changes in cognitive functions and motor coordination in their offspring. Pinealon was observed to help protect neurons from oxidative stress, reducing the accumulation of reactive oxygen species and necrotic cell death in the brain. These effects provide evidence of the neuroprotective properties of Pinealon and suggest that this peptide may be of interest in research into protecting nerve cells from stress-induced damage.
Further research confirmed that Pinealon influences neuronal resistance to hypoxic stress by stimulating antioxidant enzyme systems in the body and limiting the excitotoxic effects of N-methyl-D-aspartate (NMDA). NMDA is known to cause neuronal damage in various neurodegenerative diseases. Additionally, Pinealon influences the production of irisin, a hormone released from skeletal muscles during exercise, which has been studied in the context of cell protection, fat metabolism, and telomere length. Increased levels of irisin in the brain have been associated with changes in memory and learning in research models, suggesting relevance to central nervous system research. These studies indicate that Pinealon could be of interest as a research tool for neuron protection and aging processes in the brain.
[5] - [8]
4. Pinealon and Symptoms of Depression
The peptides Glu-Asp-Arg (Penealon) and Lys-Glu-Asp have demonstrated the ability to stimulate serotonin expression in aging cortical cell cultures, regulating the gene for 5-hydroxytryptophanase, which is crucial for serotonin synthesis. Molecular docking studies revealed that the nucleotide sequence CCTGCC in the 5-hydroxytryptophanase gene is complementary to these peptides, suggesting that the epigenetic regulation of serotonin synthesis could be the basis for the neuroprotective and geroprotective effects of these peptides.
Further research in cortical cell cultures suggests that Pinealon may influence serotonin production through epigenetic changes, thereby increasing the activity of 5-hydroxytryptophanase. This process is of research interest not only for the neuroprotective effects of serotonin but also for its potential relevance to the study of depression, where the mechanism of naturally influencing serotonin production could be investigated alongside selective serotonin reuptake inhibitors (SSRIs) and their side effects.
[9]
5. Pinealon and Cell Death
Research on the effects of Pinealon (Glu-Asp-Arg) has shown its significant potential in research into cognitive functions and protecting brain cells from damage caused by hypoxia. Studies on rats have indicated that this peptide influences neurogenesis and neuroinflammatory responses in acute hypoxia, with observed changes in cognitive outcomes and markers of oxidative stress. Pinealon reduces reactive oxygen species (ROS) in brain tissue, thereby influencing apoptosis and protecting neurons from damage, which supports its neuroprotective effects in the studied models. This mechanism is also confirmed by its effects on the inhibition of caspase-3, a key enzyme responsible for cell death.
In addition to its neuroprotective effects in research models, Pinealon has shown activity in other cell types, including those involved in tissue regeneration. Research on rat skin cultures has shown that Pinealon influences cell proliferation and apoptosis, affecting regenerative processes in the skin. This effect has been investigated in the context of age-related skin pathologies, with studies showing that Pinealon influences cell proliferation even in older animals, affecting healing processes. In combination with its effects on the brain, Pinealon may be relevant to research into tissue regeneration and the reduction of aging effects.
Pinealon also demonstrates further research potential in the field of cardiology. In experiments with myocardial infarction, the peptide was shown to reduce caspase-3 levels, suggesting it may influence apoptosis of cardiac myocytes and tissue regeneration after a heart attack. This effect is of interest not only in the context of initial damage during infarction but also in researching longer-term consequences such as myocardial remodeling. These findings suggest that Pinealon could be of research interest in the context of acute myocardial infarction and its aftermath.
These studies suggest the broad research potential of Pinealon, which may be relevant not only in neuroprotective research but also in tissue regeneration and the investigation of conditions related to tissue damage, such as heart attacks or chronic injuries. This peptide could be part of new research approaches into aging and cell regeneration, contributing to further investigation of cellular health and function.
[10] - [12]
6. Pinealon and Its Effect on Sleep
A study focusing on the impact of Pinealon and Cortexin on neurobehavioral status revealed significant differences in the prevalence of psychological disorders between truck drivers and machinists. Truck drivers showed a markedly higher incidence of unstable psychological adaptation and borderline mental disorders compared to the control group. The findings suggest that the main factors affecting the emotional and psychological balance of truck drivers were work-related risks and long-term exposure to stress associated with their work schedule. In contrast, age was the significant factor among machinists. The study also demonstrated that bioregulatory peptides, such as Pinealon, may influence the body's adaptive potential, emotional state, and resistance to work-related stress.
In addition to influencing psychoemotional indicators, it was shown that Pinealon also affects the regulation of sleep cycles, which is particularly relevant to research into individuals with sleep disorders caused by irregular work schedules or other factors. Research suggests that Pinealon can influence pineal gland function, with observed associations with sleep quality, mood, blood pressure, and general bodily function. Disrupted sleep is associated in the literature with many negative health outcomes, including impaired cognition and increased risk of heart disease. Based on these results, Pinealon presents a promising subject of research for investigating the consequences of work-related risks and sleep disturbances.
[13]
References
- L. I. Fedoreyeva, I. I. Kireev, V. K. Khavinson, and B. F. Vanyushin, "Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA," Biochem. Biokhimiia, vol. 76, no. 11, pp. 1210–1219, Nov. 2011.
- V. N. Meshchaninov, E. L. Tkachenko, S. V. Zharkov, I. V. Gavrilov, and I. E. Katyreva, "[EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION]," Adv. Gerontol. Uspekhi Gerontol., vol. 28, no. 1, pp. 62–67, 2015.
- V. K. Khavinson, B. I. Kuznik, S. I. Tarnovskaya, and N. S. Lin'kova, "Short Peptides and Telomere Length Regulator Hormone Irisin," Bull. Exp. Biol. Med., vol. 160, no. 3, pp. 347–349, Jan. 2016.
- K. S. Rana et al., "Plasma irisin levels predict telomere length in healthy adults," Age Dordr. Neth., vol. 36, no. 2, pp. 995–1001, Apr. 2014.
- A. Arutjunyan, L. Kozina, S. Stvolinskiy, Y. Bulygina, A. Mashkina, and V. Khavinson, "Pinealon protects the rat offspring from prenatal hyperhomocysteinemia," Int. J. Clin. Exp. Med., vol. 5, no. 2, pp. 179–185, 2012.
- V. Khavinson et al., "Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes," Rejuvenation Res., vol. 14, no. 5, pp. 535–541, Oct. 2011.
- L. S. Kozina, "[Investigation of antihypoxic properties of short peptides]," Adv. Gerontol. Uspekhi Gerontol., vol. 21, no. 1, pp. 61–67, 2008.
- J. Zhang and W. Zhang, "Can irisin be a linker between physical activity and brain function?," Biomol. Concepts, vol. 7, no. 4, pp. 253–258, Aug. 2016.
- V. K. Khavinson, N. S. Lin'kova, S. I. Tarnovskaya, R. S. Umnov, E. V. Elashkina, and A. O. Durnova, "Short peptides stimulate serotonin expression in cells of brain cortex," Bull. Exp. Biol. Med., vol. 157, no. 1, pp. 77–80, May 2014.
- A. M. Mendzheritskiĭ, G. V. Karantysh, G. A. Ryzhak, and S. V. Dem'ianenko, "[Regulation of content of cytokines in blood serum and of caspase-3 activity in brains of old rats in model of sharp hypoxic hypoxia with Cortexin and Pinealon]," Adv. Gerontol. Uspekhi Gerontol., vol. 27, no. 1, pp. 94–97, 2014.
- "Serum Caspase-3 p17 Fragment Is Elevated in Patients With ST-Segment Elevation Myocardial Infarction | JACC: Journal of the American College of Cardiology." [Online]. Available: http://www.onlinejacc.org/content/57/2/220. [Accessed: 11-Jun-2019].
- M. A. Voicekhovskaya, N. I. Chalisova, E. A. Kontsevaya, and G. A. Ryzhak, "Effect of bioregulatory tripeptides on the culture of skin cells from young and old rats," Bull. Exp. Biol. Med., vol. 152, no. 3, pp. 357–359, Jan. 2012.
- A. S. Bashkireva and V. G. Artamonova, "[The peptide correction of neurotic disorders among professional truck-drivers]," Adv. Gerontol. Uspekhi Gerontol., vol. 25, no. 4, pp. 718–728, 2012.
